Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000080

CHIEF EXECUTIVE OFFICER sold 7,098 shares at an average $109.21 ($775,154)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −310 $107.27 $33,253 141,820 I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −887 $108.72 $96,437 140,933 I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −2,113 $109.58 $231,549 138,820 I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −239 $110.35 $26,373 138,581 I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −356 $107.50 $38,269 141,774 I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −807 $108.75 $87,760 140,967 I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −1,849 $109.43 $202,334 139,118 I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2024-10-07 Sale 10b5-1 −537 $110.20 $59,180 138,581 I
Open-market sales · 7,098 sh · avg $109.21 · $775,154
Loading xslF345X05/wk-form4_1728433940.xml…